Join
Live feed
·
INSIDERFilingvia Quantisnow
Millendo Therapeutics, Inc. logo

SEC Form 4: Dubensky Thomas W. was granted 111,343 units of Common Stock

ByQuantisnow·Wall Street's wire, on your screen.
MLND· Millendo Therapeutics, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MLND (Millendo Therapeutics, Inc. ) and more on Quantisnow.

SEC Form 4: Dubensky Thomas W. was granted 111,343 units of Common Stock | Quantisnow